New plant-based treatment aims to fight chemo fatigue in breast cancer patients
NCT ID NCT07669506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tested whether Nuvastatic, a plant extract, can reduce cancer-related fatigue in 180 women with breast cancer undergoing chemotherapy. Participants took Nuvastatic or a placebo three times daily for three chemo cycles. The study measured fatigue levels and quality of life using standard questionnaires. The goal is to find a safe, natural way to help patients feel less exhausted during treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nuvastatic (a plant extract)
What this could lead to
If it works, this could offer a natural option to ease severe fatigue during chemotherapy, helping patients feel better day-to-day.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. Fatigue is subjective, and the placebo effect can be strong. The extract may not outperform placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Avicenna Hospital
Lucknow, Uttar Pradesh, 226016, India
-
Department of Medical Oncology (In Charge - Oncology Unit), Govt. Medical College & Govt. General Hospital,
Srikakulam, Andhra Pradesh, 532001, India
-
Hanji Cancer Centre
Belagavi, Karnataka, 590006, India
-
K.R. Hospital, Mysore Medical College & Research Institute
Mysuru, Karnataka, 570001, India
-
Onco-Life Cancer Centre
Satara, Maharashtra, 415519, India
-
Onco-Life Cancer Centre, Pvt. Ltd (Talegaon General Hospital)
Talegaon Dābhāde, Maharashtra, 410506, India
-
Siddharth Gupta Memorial Cancer Hospital (A Unit of Acharya Vinoba Bhave Rural Hospital)
Wardha, Maharashtra, 442004, India